Filing Flows › Cardio Diagnostics Holdings (CDIO) › Q2 2026
Cardio Diagnostics Holdings (CDIO) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 7, 2026
Cardio Diagnostics Holdings (CDIO) reported revenue of $5K for the second quarter 2026 (Q2 2026), -28% from a year earlier and +100% from the quarter before.
Cardio Diagnostics Holdings, Q2 2026: revenue $5K (-28% year over year), net loss $1.5M, operating cash flow −$1.3M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5K | +100% | -28% |
| Operating profit | −$1.5M | — | — |
| Net earnings | −$1.5M | — | — |
| Operating cash flow | −$1.3M | — | — |
What changed
Revenue was $5K in Q2 2026, down 28% year over year and up 100% from the previous quarter.
Operating costs exceeded revenue by $1.5M, an operating margin of -27950.5%. Total costs fell 11% while revenue fell 28%. The quarter ended with a net loss of $1.5M, narrower than the previous quarter's $1.8M loss.
Operating cash flow was −$1.3M. Non-cash charges added back $6K of depreciation and amortization and $24K of share-based compensation. Working capital and other items added $129K.
Questions
What was Cardio Diagnostics Holdings' revenue in the second quarter 2026?
Cardio Diagnostics Holdings (CDIO) reported revenue of $5K for the second quarter 2026 (Q2 2026), -28% from a year earlier and +100% from the quarter before.